ArticleBMJ (Clinical research ed.)2012
Prognosis in women with interval breast cancer: population based observational cohort study.
Article in BMJ (Clinical research ed.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.
- Assessment of cancer screening effectiveness in the era of screening programs.European journal of epidemiology · 2020Pooled it
- Machine learning-based prediction of breast cancer growth rate in vivo.British journal of cancer · 2019Trial
- Public health determinants of screening accessibility, diagnostic and treatment timeliness, care adherence, and survival outcomes in breast cancer patients.Frontiers in public health · 2026Article
- Risk factors for interval breast cancer: insights from a decade of a mammography screening program.Breast cancer research and treatment · 2025Article
- External Validation of a Commercial Artificial Intelligence Algorithm on a Diverse Population for Detection of False Negative Breast Cancers.Journal of breast imaging · 2025Article
- Genetic landscape of interval and screen detected breast cancer.NPJ precision oncology · 2024Article
- Risk Factors and Mortality Among Women With Interval Breast Cancer vs Screen-Detected Breast Cancer.JAMA network open · 2024Article
- Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast Cancers.JAMA network open · 2020Observational
- Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.JAMA network open · 2020Article
- Five-Year Overall Survival of Interval Breast Cancers is Better than Non- Interval Cancers from Korean Breast Cancer Registry.Asian Pacific journal of cancer prevention : APJCP · 2019Article
- Discontinuation of adjuvant hormone therapy among breast cancer patients not previously attending mammography screening.BMC medicine · 2019Article
- Localized mammographic density is associated with interval cancer and large breast cancer: a nested case-control study.Breast cancer research : BCR · 2019Article
- Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers.BMC cancer · 2018Article
- The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening.NPJ breast cancer · 2017Article
- Expected 10-year treatment cost of breast cancer detected within and outside a public screening program in Norway.The European journal of health economics : HEPAC : health economics in prevention and care · 2016Article
- Benefits and harms of mammography screening.Breast cancer research : BCR · 2015Review
- Evaluation of Breast Cancer Cases Diagnosed In the Breast Cancer Screening Program In the Near East University Hospital of North Cyprus.The journal of breast health · 2015Article
- Survival analysis of patients with interval cancer undergoing gastric cancer screening by endoscopy.PloS one · 2015Article
- Breast cancer survival and prognosis by screening history.British journal of cancer · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo compare the prognosis in women with interval breast cancer (cancer detected after a normal screening mammogram and before the next scheduled mammogram) with breast cancer detected among women not yet invited to mammography screening (non-screened).
designPopulation based observational study.
settingNorwegian breast cancer screening programme, implemented in different counties from 1996 to 2005.
participants7116 women with a diagnosis of breast cancer at age 50 to 72 years; 1816 had interval breast cancer and 5300 had a diagnosis of breast cancer but had not yet been invited to screening.
main outcome measuresCharacteristics of the breast tumours, and survival of the women using Kaplan Meier curves and multivariable Cox proportional hazard models.
resultsAlthough interval cancers on average were slightly larger than the cancers in women not invited to screening, the histological type or status of axillary lymph nodes did not differ noticeably between the two groups. Among interval cancers, there were no appreciable trends in size, nodal status, grade, or hormone receptor positivity associated with time since the last normal mammogram as a marker of growth rate. After 10 years of follow-up, the survival rates were 79.1% (95% confidence interval 75.4% to 82.3%) among women with interval cancers and 76.8% (75.3% to 78.2%) among women in the non-screened cancer group (hazard ratio 0.98, 95% confidence interval 0.84 to 1.15; P=0.53). Analyses stratified by time since last normal mammogram, age at diagnosis, or screening round showed similar results.
conclusionThe prognosis of women with interval breast cancers was the same as that of women with breast cancers diagnosed without mammography screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.